Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancer.

Por Fragasso, G., Tresoldi, M., Benti, R., Vidal, M., Marcatti, M., Borri, A., Besana, C., Gerundini, P. P., Rugarli, C., Chierchia, S.
Publicado em 1994

The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation

Por Frenquelli, M, Caridi, N, Antonini, E, Storti, F, Viganò, V, Gaviraghi, M, Occhionorelli, M, Bianchessi, S, Bongiovanni, L, Spinelli, A, Marcatti, M, Belloni, D, Ferrero, E, Karki, S, Brambilla, P, Martinelli-Boneschi, F, Colla, S, Ponzoni, M, DePinho, RA, Tonon, G
Publicado no Leukemia (2020)

Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia

Por Greco, R, Mancini, N, Peccatori, J, Cieri, N, Vago, L, Giglio, F, Morelli, M, Ghidoli, N, Carletti, S, Levati, G, Crucitti, L, Sala, E, Lupo Stanghellini, M T, Lorentino, F, Forcina, A, Pavesi, F, Carrabba, M, Marktel, S, Assanelli, A, Marcatti, M, Bernardi, M, Corti, C, Doglioni, C, Scarpellini, P, Burioni, R, Bonini, C, Clementi, M, Ciceri, F
Publicado em 2014